Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System

During normal development of the nervous system (NS), neural progenitor cells (NPCs) produce specialized populations of neurons and glial cells upon cell fate restriction and terminal differentiation. These sequential processes require the dynamic regulation of thousands of genes. The calcium-sensing receptor (CaSR) is temporally and spatially regulated in both neurons and glial cells during development of the NS. In particular, CaSR expression and function have been shown to play a significant role during differentiation of NPCs toward the oligodendrocyte lineage and also in maturation of cerebellar granule cell precursors (GCPs). Moreover, CaSR regulates axonal and dendritic growth in both central and peripheral nervous systems (PNSs), a process necessary for proper construction of mature neuronal networks. On the other hand, several lines of evidence support a role for CaSR in promotion of cell differentiation and inhibition of proliferation in neuroblastoma, a tumor arising from precursor cells of developing PNS. Thus, among the variety of NS functions in which the CaSR participates, this mini-review focuses on its role in differentiation of normal and tumoral cells. Current knowledge of the mechanisms responsible for CaSR regulation and function in these contexts is also discussed, together with the therapeutic opportunities provided by CaSR allosteric modulators.

[1]  V. L. Schermer,et al.  Book Review: Ruptures in the American Psyche: Containing Destructive Populism in Perilous Times , 2022, Group Analysis.

[2]  D. Hampson,et al.  The calcium‐sensing receptor and integrins modulate cerebellar granule cell precursor differentiation and migration , 2016, Developmental neurobiology.

[3]  J. Mora,et al.  Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens , 2016 .

[4]  W. Janssen,et al.  c-Myc-dependent transcriptional regulation of cell cycle and nucleosomal histones during oligodendrocyte differentiation , 2014, Neuroscience.

[5]  A. Fernandes,et al.  Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination. , 2014, Biochimica et biophysica acta.

[6]  W. Weiss,et al.  The prenatal origins of cancer , 2014, Nature Reviews Cancer.

[7]  K. Kalil,et al.  Branch management: mechanisms of axon branching in the developing vertebrate CNS , 2013, Nature Reviews Neuroscience.

[8]  William A Weiss,et al.  Neuroblastoma and MYCN. , 2013, Cold Spring Harbor perspectives in medicine.

[9]  F. Bruggeman,et al.  Calcium sensing receptor signalling in physiology and cancer. , 2013, Biochimica et biophysica acta.

[10]  Andrew P. Feinberg,et al.  Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host , 2013, Nature Reviews Cancer.

[11]  M. Ruat,et al.  Roles of the calcium sensing receptor in the central nervous system. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[12]  Michael A. Dyer,et al.  Neuroblastoma: developmental biology, cancer genomics and immunotherapy , 2013, Nature Reviews Cancer.

[13]  D. Miao,et al.  Calcium Sensing Receptor Absence Delays Postnatal Brain Development via Direct and Indirect Mechanisms , 2013, Molecular Neurobiology.

[14]  J. Mora,et al.  Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma , 2013, PloS one.

[15]  J. Jui,et al.  Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. , 2013, Cell reports.

[16]  J. Mora,et al.  The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis. , 2012, Carcinogenesis.

[17]  Stanley He,et al.  MYCN and the epigenome , 2013, Front. Oncol..

[18]  Steven J. M. Jones,et al.  The genetic landscape of high-risk neuroblastoma , 2013, Nature Genetics.

[19]  M. Bronner,et al.  Development and evolution of the neural crest: an overview. , 2012, Developmental biology.

[20]  Shazia Tanvir,et al.  Effects of WCDMA modulated TF exposure on the structure and function of the human , 2012 .

[21]  D. Zwijnenburg,et al.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes , 2012, Nature.

[22]  D. Riccardi,et al.  The calcium-sensing receptor beyond extracellular calcium homeostasis: conception, development, adult physiology, and disease. , 2012, Annual review of physiology.

[23]  S. Påhlman,et al.  Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage. , 2011, Seminars in cancer biology.

[24]  A. Xiao,et al.  Epigenetic regulation in neural crest development. , 2011, Birth defects research. Part A, Clinical and molecular teratology.

[25]  R. Stallings,et al.  Co-Localization of the Oncogenic Transcription Factor MYCN and the DNA Methyl Binding Protein MeCP2 at Genomic Sites in Neuroblastoma , 2011, PloS one.

[26]  R. Morgan,et al.  Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer. , 2011, Cancer research.

[27]  A. Bird,et al.  CpG islands and the regulation of transcription. , 2011, Genes & development.

[28]  M. Maio,et al.  The biology of cancer testis antigens: Putative function, regulation and therapeutic potential , 2011, Molecular oncology.

[29]  G. Raschellà,et al.  Addiction of MYCN Amplified Tumours to B-MYB Underscores a Reciprocal Regulatory Loop , 2010, Oncotarget.

[30]  S. Bandyopadhyay,et al.  Diverse roles of extracellular calcium‐sensing receptor in the central nervous system , 2010, Journal of neuroscience research.

[31]  J. Maris Recent advances in neuroblastoma. , 2010, The New England journal of medicine.

[32]  Y. Gotoh,et al.  Epigenetic control of neural precursor cell fate during development , 2010, Nature Reviews Neuroscience.

[33]  W. Weiss,et al.  Myc proteins as therapeutic targets , 2010, Oncogene.

[34]  Raymond L. Stallings,et al.  Global MYCN Transcription Factor Binding Analysis in Neuroblastoma Reveals Association with Distinct E-Box Motifs and Regions of DNA Hypermethylation , 2009, PloS one.

[35]  P. Cartron,et al.  Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation , 2009, Epigenetics.

[36]  J. Mora,et al.  The calcium‐sensing receptor and parathyroid hormone‐related protein are expressed in differentiated, favorable neuroblastic tumors , 2009, Cancer.

[37]  Gudrun Schleiermacher,et al.  Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma , 2008, Nature.

[38]  S. Bandyopadhyay,et al.  Calcium receptor expression and function in oligodendrocyte commitment and lineage progression: Potential impact on reduced myelin basic protein in CaR‐null mice , 2008, Journal of neuroscience research.

[39]  A. Davies,et al.  Regulation of axonal and dendritic growth by the extracellular calcium-sensing receptor , 2008, Nature Neuroscience.

[40]  A. Spiegel,et al.  Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators , 2007, Journal of cellular and molecular medicine.

[41]  S. Giannini,et al.  R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. , 2007, Kidney international.

[42]  K. Siminovitch,et al.  Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnostics. , 2007, Clinical biochemistry.

[43]  U. Armato,et al.  Roles of Ca2+ and the Ca2+‐sensing receptor (CASR) in the expression of inducible NOS (nitric oxide synthase)‐2 and its BH4 (tetrahydrobiopterin)‐dependent activation in cytokine‐stimulated adult human astrocytes , 2005, Journal of cellular biochemistry.

[44]  Antonio Porro,et al.  In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. Perilongo,et al.  Childhood solid tumours: a developmental disorder , 2005, Nature Reviews Cancer.

[46]  L. Muscarella,et al.  Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. , 2004, The Journal of clinical endocrinology and metabolism.

[47]  M. Mori,et al.  GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  W. Gerald,et al.  Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. , 2004, Journal of the National Cancer Institute.

[49]  H. Shimada,et al.  The International Neuroblastoma Pathology Classification. , 2003, Pathologica.

[50]  A. Graham,et al.  The neural crest , 2003, Current Biology.

[51]  G. Brodeur Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[52]  R. Eisenman,et al.  N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. , 2002, Genes & development.

[53]  C. Eng,et al.  RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours , 2001, Oncogene.

[54]  D. Stram,et al.  International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors , 2001, Cancer.

[55]  A. Iavarone,et al.  Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins , 2000, Nature.

[56]  E. Brown,et al.  Regulation of secretion of PTHrP by Ca(2+)-sensing receptor in human astrocytes, astrocytomas, and meningiomas. , 2000, American journal of physiology. Cell physiology.

[57]  J. Stinnakre,et al.  Developmental and adult expression of rat calcium‐sensing receptor transcripts in neurons and oligodendrocytes , 2000, The European journal of neuroscience.

[58]  E. Brown,et al.  Extracellular calcium-sensing receptor induces cellular proliferation and activation of a nonselective cation channel in U373 human astrocytoma cells , 1999, Brain Research.

[59]  K K Matthay,et al.  The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.

[60]  F. Speleman,et al.  Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. , 1999, The New England journal of medicine.

[61]  E. Brown,et al.  The Extracellular Calcium‐Sensing Receptor Is Expressed in Rat Microglia and Modulates an Outward K+ Channel , 1999, Journal of neurochemistry.

[62]  Hiroyuki Tanaka,et al.  A986S polymorphism of calcium-sensing receptor , 1999, The Lancet.

[63]  G. Hawker,et al.  A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations , 1999, The Lancet.

[64]  E. Brown,et al.  Extracellular calcium‐sensing receptor in rat oligodendrocytes: Expression and potential role in regulation of cellular proliferation and an outward K+ channel , 1998, Glia.

[65]  M F Balandrin,et al.  Calcimimetics with potent and selective activity on the parathyroid calcium receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. A. Weston,et al.  Timing and pattern of cell fate restrictions in the neural crest lineage. , 1997, Development.

[67]  E. Brown,et al.  Calcium-sensing receptor in the rat hippocampus: a developmental study. , 1997, Brain research. Developmental brain research.

[68]  E. Brown,et al.  Localization of calcium receptor mRNA in the adult rat central nervous system by in situ hybridization , 1997, Brain Research.

[69]  P. Ambros,et al.  Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. , 1996, The New England journal of medicine.

[70]  M. Leppert,et al.  Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. , 1996, The Journal of clinical endocrinology and metabolism.

[71]  J. Herman,et al.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.

[72]  J. Seidman,et al.  A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 1995, Nature Genetics.

[73]  S. Snyder,et al.  Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[74]  M. Hediger,et al.  Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid , 1993, Nature.

[75]  A. Cantor,et al.  Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. , 1993, The New England journal of medicine.

[76]  D. Anderson,et al.  Antibody markers identify a common progenitor to sympathetic neurons and chromaffin cells in vivo and reveal the timing of commitment to neuronal differentiation in the sympathoadrenal lineage , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[77]  David J. Anderson,et al.  A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids , 1986, Cell.

[78]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[79]  J. Trent,et al.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.

[80]  H. B. Marsden,et al.  Histologic patterns of neuroblastoma related to prognosis and clinical staging , 1974, Cancer.

[81]  Ruth Lundeen Memmler,et al.  Structure and function of the human body , 1970 .

[82]  M. V. van Noesel,et al.  Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest. , 2012, The Lancet. Oncology.

[83]  L. Muscarella,et al.  Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. , 2007, The Journal of clinical endocrinology and metabolism.

[84]  E. Brown,et al.  In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. , 1997, The Journal of clinical investigation.

[85]  F. Alt,et al.  Differential expression of myc family genes during murine development , 1986, Nature.